Generating AI analysis...
AI Earnings Analysis
| Metric | Current | Previous | YoY Change |
|---|---|---|---|
Revenue | $1.27B | $2.27B | -44.23% |
Cost of Revenue | $416M | $725M | -42.62% |
Operating Income | $-2.22B | $-2.7B | +17.86% |
Net Income | $-2B | $-2.44B | +18.23% |
EPS (Basic) | $-5.15 | $-6.37 | +19.15% |
EPS (Diluted) | $-5.15 | $-6.37 | +19.15% |
R&D Expense | $2.36B | $3.42B | -31.10% |
| Metric | Current | Previous | YoY Change |
|---|---|---|---|
Total Assets | $12.13B | $15.8B | -23.21% |
Current Assets | $6.6B | $9.67B | -31.74% |
Total Liabilities | $2.81B | $3.88B | -27.63% |
Current Liabilities | $1.68B | $2.2B | -23.63% |
Stockholders' Equity | $9.33B | $11.93B | -21.77% |
Cash & Equivalents | $1.13B | $1.64B | -31.14% |
| Metric | Current | Previous | YoY Change |
|---|---|---|---|
Operating Cash Flow | $-2.8B | $-3.83B | +26.80% |
Investing Cash Flow | $1.99B | $2.49B | -19.86% |
Financing Cash Flow | $12M | $59M | -79.66% |
D&A | $145M | $126M | +15.08% |
| Metric | Current | Previous | YoY Change |
|---|---|---|---|
Operating Margin | -175.1% | -118.9% | -56.22% |
Net Margin | -157.7% | — | — |
ROE | -21.4% | — | — |
ROA | -16.4% | — | — |
Current Ratio | $3.925 | — | — |
Debt to Equity | $0.301 | — | — |
Other companies in Biotechnology